bcva examiner training and certification lilly bdad clinical trial © 2009 the emmes corporation

80
BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Upload: virgil-francis

Post on 14-Dec-2015

246 views

Category:

Documents


9 download

TRANSCRIPT

Page 1: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

BCVA Examiner

Training and Certification

Lilly BDAD Clinical Trial

© 2009 The EMMES Corporation

Page 2: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Training Objectives

• Review Examination Lane set up

• Train in protocol methods of performing the following tasks:• ETDRS Refraction

• ETDRS Visual Acuity

• Completion of Worksheets related to the above tasks

• Review responsibilities

• Review certification requirements

Page 3: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Examination Lane

Page 4: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Exam Lane Requirements• 4 meter space

• ETDRS light box

• ETDRS Charts R, 1, & 2

• Trial lens set• With – 0.37 lens

• Jackson Cross Cylinders• 0.25, 0.50, 1.00

• Trial frames

• Meter stick

• Primary & spare light tubes• With fenestrated sleeves

• Burn-in & change documentation

-0.37

Page 5: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Examination Lane

• Established sites have the examination lane already configured

• Lane requirements are covered in the EMMES training manual

• Examination lane certification is granted by:• EMMES certifier during EMMES site visit

• Grandfathering • From Sponsor’s previous clinical trial

• From previous EMMES site visit

Page 6: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Refraction

Page 7: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Refraction• Acceptable baselines:

• Phoropter• Autorefractor• Retinoscopy• Lensometry• Last visit Refraction in trial frames

• Sphere and Cylinder

• Final refinement must be done using trial lenses in trial frames and the Jackson Cross Cylinder (JCC)

Page 8: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Trial Lens Set

• Loose spherical and cylindrical lenses• Used for ETDRS

refraction and visual acuity measurement

• Plus and minus power spherical lenses

• Cylinders may be plus, minus, or both

Page 9: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

-0.37 Sphere

• Additional lens needed in Lilly BDAD Study

• Not usually included in trial lens set and may need to be ordered separately

• Site must obtain this lens before start of study

- 0.37

Page 10: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Jackson Cross Cylinder

• Used to check for axis and power of cylinder

• Site must have JCC in three powers:

• 0.25

• 0.50

• 1.00

Page 11: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Trial Frames

• Must be comfortable for the subject to wear

• Must be in good repair with no broken or missing parts

• Several types are available• Trial lenses are inserted into

lens cells for refraction and visual acuity measurement

Page 12: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Technique

Page 13: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Refraction

• For visual acuity of 20/80 or better• Start with +0.50 and -0.37 spherical lenses

• Start with +0.25 cylinder at axis 180o

• If using minus cylinder, begin with -0.25 at axis 90o

• For visual acuity worse than 20/80• Use higher diopter power spheres and cylinders

• Refer to BCVA Guidelines sheet for each step• Step 1: Initial sphere power

• Step 2: Cylinder – axis and power

• Step 3: Final sphere power

Page 14: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Initial Sphere

Page 15: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Refraction

• Use Chart R

• Begin with right eye

• Refine:• Initial sphere

• Cylinder (axis and power)

• Final sphere

Chart R

Page 16: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Sphere• Ask subject to read smallest line they are

able to see on Chart R as a starting point

• Select beginning lens from BCVA Guidelines based on this reading

• As vision improves with addition of lenses, use lens appropriate for the vision at each point during testing

Page 17: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Refraction Chart R

• Ask subject if lens makes the letters• Better

• Worse

• No Different

• Do not say “Better 1 or 2”

Page 18: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Push Plus

• “Push Plus” – determine highest plus or least minus that produces minimal blur• Offer +0.50 sphere and give +0.50 sphere as long

as it is “Better” or “No Different”

• Once +0.50 sphere is “Worse” • Ask subject to read smallest line they are able to

read• Necessary as when minus is offered, subject must earn

minus by reading more letters on the chart

Page 19: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Offer Minus

• Offer -0.37 minus sphere

• If “Better,” subject must earn minus by reading at least one more letter• If earned, give -0.25 sphere

• Continue to offer -0.37 sphere until “Worse” or “No Different”

- 0.37

Page 20: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Offer Plus

• After minus has been offered, earned, and adjusted – that is, “worse” or “no different”

• Offer +0.50 again and ask if “Better, Worse, or No Different”• Offer and give plus until plus is “Worse”

• Always end up offering plus

Page 21: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Refraction at 1 Meter

• Refract both eyes at 4 meters

• If fewer than 4 letters are read at 4 meters, move subject to 1 meter• Carefully measure with 1 meter stick

• Add +0.75 sphere to distance refraction• Remember to take this out when recording refraction

worksheet

• Both eyes are refracted at 4 meters before moving subject to 1 meter

Page 22: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Cylinder

Page 23: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Cylinder

• Do not estimate the cylinder or use only the spherical refraction

• Use cylinder from autorefractor or retinoscopy as a starting point• It must be refined and finalized using the Jackson

Cross Cylinder

• Use JCC power according to BCVA Guidelines

• Refine cylinder axis and cylinder power

Page 24: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

JCC Flips and Rotates• JCC with power dots • JCC with power lines

White & green are plus power

Red is minus power

Page 25: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Axis Refinement

Page 26: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Instructions to Subject

• For axis refinement, instruct the subject to find the smallest line read comfortably and concentrate on a round letter one line above• Smallest line read

• Instruct subject to concentrate here

Page 27: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Axis Refinement

• When refining the cylinder axis, follow the handle of the JCC • Offers plus and minus power 45o from

beginning axis alignment

- 1.0

0

Page 28: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Axis Refinement

• If working in minus cylinder, “chase” the minus line or dot

• Rotate the lens axis 5 – 15o

- 1.0

0

Page 29: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Axis Refinement• Now place the JCC with handle at the new

axis and continue to flip, asking “Better 1 or 2, or about the same”• Continue to chase the prefered line or dot

- 1.0

0

Page 30: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Axis Refinement• Continue to rotate the axis and the JCC

according to the subject’s responses• It may be necessary to use smaller degree

changes as the end point gets closer or if there is high cylinder power

- 1.0

0

Page 31: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Axis Refinement

• As long as the response is a number, continue to flip the JCC to refine the axis• Correct axis has been determined when the

subject’s response is “about the same”

• Cylinder axis must be determined before determining the correct cylinder power

Page 32: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Power Refinement

Page 33: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Instructions to Subject

• For power refinement, instruct the subject to find the smallest line read comfortably and concentrate on a round letter on that line• Smallest line read

• Instruct subject to concentrate here

Page 34: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Power Refinement

• When refining the cylinder power, follow the power dots or power lines • Offers plus and minus power on the refined axis

- 1.0

0

Page 35: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Power Refinement

• Continue to offer power and exchange trial lens until subject’s response is “about the same”

• Correct power has now been determined

- 1.2

5-

1.5

0

Page 36: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Spherical Equivalent

• Once 0.50 diopter of cylinder has been added or subtracted, adjust the sphere by 0.25 of opposite power• -0.50 cylinder added: give +0.25 sphere

• -0.50 cylinder taken away: give -0.25 sphere

• Adjust the sphere as you go – do not wait until the cylinder power is fully determined

Page 37: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Refraction – Cylinder

• If there is established cylinder from last Refraction:• Refine axis using Jackson Cross Cylinder

• Follow the handle of the JCC

• Refine power using JCC

• When checking cylinder, the choices given the subject are:• “Better 1 or 2 or about the same”

Page 38: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Cylinder

• If cylinder is unknown:• Test for astigmatism by placing a +0.25 cylinder

first at 180o and then at 90o if the first choice is not satisfactory (or -0.25 at 90o if working in minus cylinder)

• Refine the axis and power with Jackson Cross Cylinder (JCC)• Follow the color line or dot of the cylinder you

are working in

• Move the axis 5o – 15o or smaller increments as axis is refined

Page 39: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Final Sphere Refinement

Page 40: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Final Sphere

• Ask subject to read smallest line they are now able to see on Chart R

• Select refinement lens from BCVA Guidelines based on this reading

• As vision improves with addition of lenses, use lens appropriate for the vision at each point during testing

Page 41: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Refraction – Final Sphere

• Offer +0.25 and ask if “Better, Worse, or No Different”• Offer and give plus until plus is “Worse”

• Check visual acuity before offering minus

• Offer -0.37 sphere and give -0.25 if minus is better and more letters are read

• Offer +0.25 to finish Refraction

• If final sphere changes by ≥ 0.50 diopter, re-check the cylinder axis and power

Page 42: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Visual Acuity

Page 43: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Points of Note

• Always test the right eye first

• Use Chart 1 for the right eye

• Use Chart 2 for the left eye

• If < 20 letters are read correctly, the subject must be tested at 1 meter• Add +0.75 sphere to distance refraction

• If the subject must be moved to 1 meter, both eyes should be tested at 4 meters before moving the subject to 1 meter

Page 44: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Points of Note

• Give the subject detailed instructions before testing begins

• Start at the upper left corner – read left to right

• There are no numbers – only letters

• Read slowly – one letter per second

• It is acceptable and encouraged to guess letters

• Corrections should be made before going on to the next letter

Page 45: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

ETDRS Charts

• 10 alphabet letters

• Sloan letters

• Random order

• Same degree of difficulty for each letter

Page 46: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Points of Note

• If subject loses their place on the chart• Verbally orient place

• By row number from the top of the chart

• Do not ask for row lower than 3rd or 4th

• By horizontal lines on the chart

• Do not• Repeat the last line read

• Point to the chart

1

2

3

Page 47: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

BCVA Examiner Responses

• Do not stop the subject if they give an incorrect response

• Do not comment as the subject responds• “OK” or “yes” should not be said after each letter,

nor should nods or other gestures be made• Once the examiner does not respond, the subject

knows they have given an incorrect response

• Testing must be completely unbiased on the part of the BCVA examiner

Page 48: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Subject Questions

• If the subjects asks if it is a certain letter, the BCVA examiner should ask them to choose the letter they think it is

• If the subject attempts to skip letters – “the third letter looks like...,” the BCVA examiner should immediately stop them and ask them to begin with the first letter on the left

Page 49: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Points of Note

• Encourage the subject to read as far as possible

• Do not allow subject to quit easily• Ask subject to guess letters on next line

• Allow subject the opportunity to guess any letter they may confuse with a number or another letter• Urge subject to pick one letter

Page 50: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Points of Note

• Corrections• Subject may not go back and correct a letter

once they have read the next letter

• Subject may correct before going to next letter

• Stop the subject immediately if they read letters too quickly or if they say a number• This will give them the opportunity to correct

before going to the next letter

Page 51: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Skipped Lines

• If it is obvious that the subject has skipped a line, the BCVA examiner should:• Stop the testing

• Re-orient the subject to the correct line

• Ask the subject to read that line

• Continue with the testing as if the subject had not skipped a line (i.e. – this is the only time a subject is permitted to go back as it is technically not a correction but an omission)

Page 52: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Head Position

• The subject may be permitted to turn his or her head to fixate eccentrically, provided the fellow eye is adequately occluded• The trial lens occluder may not

be adequate for this

• A tissue or eye patch may be needed• If patch used, it should be loose

enough so that subject can keep both eyes open (even though one is occluded)

• Always use at 1 meter

Page 53: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

When to Stop

• Visual acuity testing is stopped only when the subject convinces the examiner that they can read no more letters on the ETDRS chart• It is not stopped when the subject misses two

letters on a line as in some other clinical trials

Page 54: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Visual Acuity – Right Eye

• Tested at 4 meters

• Start with the right eye; occlude the left eye

• Place Chart 1 in light box• Other charts should be

out of view

Chart 1

Page 55: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Visual Acuity – Left Eye

• Tested at 4 meters

• Remove occluder lens from left eye; occlude right eye

• Remove Chart 1• Put it out of view

• Place Chart 2 in light box

Chart 2

Page 56: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Visual Acuity Testing

• Subjects unable to read at least 20 letters at 4 meters (either eye):• Seat subject 1 meter from the chart and

carefully measure the distance from the front of subject’s eye in a straight line to the front of the chart

• Add +0.75 sphere to Refraction

• Test again

• Both eyes should be tested at 4 meters before moving subject to 1 meter

Page 57: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Visual Acuity Testing

• Remove Chart 2 from view• Chart R only may be displayed in

the light box between screenings

• Testing is complete

• Score worksheets

• Check to ensure that worksheet is completely and accurately filled out• Check addition for Visual Acuity score

Page 58: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Worksheet: Refraction

• Record the 4 meter (distance) refraction on the worksheet for each eye• If any field has no power, insert zeros

• If refraction was performed at 1 meter, remember to take out the +0.75 sphere added for 1 meter testing when recording the refraction

Page 59: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

VA Worksheet Completion

• All letters read correctly should be clearly and individually circled

• Letters read incorrectly or letters subject was unable to read should be left blank

• Lines the subject attempted to read but had no correct answers should have a “0” total

• No letters read on a line should have a “0” total

Page 60: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Visual Acuity Worksheets

• Right Eye • Left Eye

Page 61: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Scoring Worksheet

C Z R H S 5

O N H R C 4

D K S N V 2

Z S O K N 2

C K D N R 0

S R Z K D 0

H Z O V C 0

Page 62: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Worksheet Example

Page 63: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Worksheet Example

Page 64: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Worksheet Example

Page 65: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Worksheet Example

Page 66: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Snellen Equivalent

• To the left of the circled responses is the “Snellen Acuity Equivalent”

• Smallest line with one or fewer incorrectly read letters • Line will have a score of 4 or 5

• Enter this in the “Visual Acuity Score” section

Page 67: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Corrections

• All worksheet or CRF corrections should be uniform:• Single line through error

• Correction inserted• If necessary, use the margin for explanation or

clarification

• Date

• Initials (or sign name)5 4 Oct 30 2009 EK

Page 68: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Common Errors

• VA score ends in a line where all 5 letters were read correctly• May indicate the subject was not encouraged to

read more letters

• Crossing out letters not circled

• Not circling letters consistently or individually

• Not counting circled letters in individual rows correctly

Page 69: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Common Errors

• Not testing subject at 1 meter if fewer than 20 letters were correctly read at 4 meters• Do not assume they would read all 30 letters

at 1 meter

• Not adding +0.75 sphere when subject is moved to 1 meter

• Not testing both eyes at 4 meters before moving subject to 1 meter

Page 70: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Site Responsibilities

Page 71: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Site Equipment

• It is the site’s responsibility to obtain all required equipment and supplies before an EMMES site visit

• Equipment procurement information is given in the EMMES training manual sent to each site

Page 72: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Exam Lane Configuration

• The Study Coordinator (or other designated individual) at the site is responsible for setting up the exam lane prior to an EMMES site visit

• Exam lane cannot be fully certified until all equipment is obtained, in place, and required documentation is in place• If site has “action items” – these must be satisfied

• e-mail documentation is acceptable

Page 73: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Exam Lane Changes

• Any changes to the exam lane should be reported to the monitor by the site

• New or changed lane must be certified before study subjects may be screened• Changes include:

• Relocation of exam lane to another room or building

• Painting or color change which may affect lighting

• Newly-installed room lighting which may affect light measurement of charts

Page 74: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Examiner

Certification

Page 75: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

BCVA Examiner Certification

• Earned during an EMMES site visit or by being grandfathered from another active EMMES certification• BCVA examiner may not screen study subjects

until full certification is granted by EMMES

• A certification number is assigned by EMMES and will be effective throughout the study for that BCVA examiner

• Certification Letter issued by EMMES• Should be kept in study binder

Page 76: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

BCVA Examiner Certification

• It is the Study Coordinator’s responsibility to ensure sufficient number of BCVA examiners are certified at site

• If BCVA examiners need to be certified by EMMES, Study Coordinator should:• Contact monitor – they will assess needs at the

site and any other sites in the general area or country• Site Visit Request will be sent to EMMES – EMMES

will contact site to schedule site visit

Page 77: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Grandfathering

• It is the Study Coordinator’s responsibility to submit the Certification Affidavit required to grandfather a BCVA examiner into the Lilly BDAD study

• Grandfathering is not automatic – the required paperwork must be submitted to EMMES• BCVA examiner may not

screen study subjects until grandfathered

Page 78: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

EMMES Contacts

• Eva Karlsson, COT: [email protected]• Ophthalmic Trainer/Certifier – Lead Point

• Lisa Motta: [email protected]• Lead Administrative Coordinator

The EMMES Corporation401 North Washington StreetRockville, MD 20850 U.S.A.Phone: 001-301-251-1161

Fax: 001-301-576-3695www.emmescertification.com

Page 79: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

Questions?

T H A N K Y O U

Page 80: BCVA Examiner Training and Certification Lilly BDAD Clinical Trial © 2009 The EMMES Corporation

R

21